Key result
The CYP17A1 rs4919686 polymorphism was significantly associated with a reduced risk of essential hypertension in the Uighur population (OR 0.559 in an additive model).
Why the study?
Does CYP17A1 genetic polymorphism associate with essential hypertension in Han and Uighur populations?
Case-Control (n=1,031)
No
Does CYP17A1 genetic polymorphism associate with essential hypertension in Han and Uighur populations?
Odds Ratio: 0.559 (95% CI 0.356–0.879)
p-value: p=0.012
CYP17A1 genetic polymorphisms are associated with essential hypertension in the Uighur population, suggesting a genetic susceptibility marker for this group.
Supports ethnic-specific genetic studies in Uighurs; hypothesis-generating and does not inform clinical practice.
The relationship between CYP17A1 genetic polymorphisms and essential hypertension (EH) remains unclear. The aim of this study was to investigate the association of CYP17A1 genetic polymorphisms with EH in Han and Uighur populations in China. A Han population including 558 people (270 EH patients and 288 controls) and a Uighur population including 473 people (181 EH patients and 292 controls) were selected. Five single-nucleotide polymorphisms (SNPs) (rs4919686, rs1004467, rs4919687, rs10786712, and rs2486758) were genotyped using real-time PCR (TaqMan). In the Uighur population, for the total and the men, rs4919686, rs4919687 and rs10786712 were found to be associated with EH (rs4919686: P≤0.02, rs4919687: P≤0.002, rs10786712: P≤0.004, respectively). The difference remained statistically significant after the multivariate adjustment (all P<0.05). The overall distributions of the haplotypes established by SNP1-SNP3, SNP1-SNP4, SNP1-SNP3-SNP5 and SNP1-SNP4-SNP5 were significantly different between the EH patients and the control subjects (for the total: P=0.013, P=0.008, P=0.032, P=0.010, for men: P<0.001, P=0.001, P=0.010, P=0.00). In the Han population, for men, rs2486758 was found to be associated with EH in a recessive model (P=0.007); the significant difference was not retained after the adjustment for the covariates (date not shown). The A allele of rs4919686 could be a susceptible genetic marker, and the T allele of rs10786712 could be a protective genetic marker of EH. The AC genotype of rs4919686, the AG genotype of rs4919687 and the TT genotype of rs10786712 could be protective genetic markers of EH.
No takes yet. Share an insight, caveat, or question.
Dai et al. (2015) conducted a case-control in Essential hypertension (n=1,031). CYP17A1 genetic polymorphisms (rs4919686) vs. Normotensive controls was evaluated on Essential hypertension (additive model) (OR 0.559, 95% CI 0.356-0.879, p=0.012). The CYP17A1 rs4919686 polymorphism was significantly associated with a reduced risk of essential hypertension in the Uighur population (OR 0.559 in an additive model).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: